Dr. Mark S Pasternack, Boston MA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
Internal Medicine Associates 15 Parkman St SUITE 6, Boston 02114 (617) 724-6200 (Phone) Massachusetts Gen Hosp-Ped Pul 275 Cambridge St SUITE 530, Boston 02114 (617) 724-0418 (Phone)
Certifications:
Infectious Disease, 1980, Internal Medicine, 1978
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Internal Medicine Associates 15 Parkman St SUITE 6, Boston 02114 Massachusetts Gen Hosp-Ped Pul 275 Cambridge St SUITE 530, Boston 02114 Massachusetts General Hospital 55 Fruit St, Boston 02114
Education:
Medical School Harvard Medical School Graduated: 1975 Massachusetts General Hospital
Mark Steven Pasternack, Boston MA
Specialties:
Infectious Disease Specialist
Address:
15 Parkman St, Boston, MA 02114 175 Cambridge St, Boston, MA 02114
Education:
Harvard Medical School - Doctor of Medicine Massachusetts General Hospital - Fellowship - Infectious Disease (Internal Medicine) Massachusetts General Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Infectious Disease (Internal Medicine)
Chief, Pediatric Infectious Disease Unit At Massachusetts General Hospital
Position:
Chief, Pediatric Infectious Disease Unit at Massachusetts General Hospital
Location:
Greater Boston Area
Industry:
Medical Practice
Work:
Massachusetts General Hospital
-
Chief, Pediatric Infectious Disease Unit
Education:
Harvard Medical School 1971 - 1975
md
Mark Steven Pasternack, Boston MA
Specialties:
Internal Medicine, Infectious Disease, Pediatrics, Transplant Surgery
Work:
Massachusetts General Hospital 55 Fruit St, Boston, MA 02114Massachusetts General Hospital 149 13Th St, Charlestown, MA 02129
Education:
Harvard University(1975)
Cytotoxic T Lymphocyte Serine Esterase And Method For Stimulation And Inhibition
US Patent:
4783410, Nov 8, 1988
Filed:
Jun 28, 1985
Appl. No.:
6/750323
Inventors:
Mark S. Pasternack - Boston MA Herman N. Eisen - Waban MA
Assignee:
Massachusetts Institute of Technology - Cambridge MA
International Classification:
C12N 916, C12N 948, C12N 976
US Classification:
435196
Abstract:
A novel serine esterase produced by cytotoxic T lymphocytes is insolated and characterized. The protein appears to be membrane bound and has a reduced apparent molecular weight of about 28,000 daltons. Inhibition of the esterase correlates with inhibition of the cells' cytolytic activity. The serine esterase is useful in making antibody and as a target for the inhibition of cytolytic activity by T-lymphocytes, both in vivo and in vitro.